ClinConnect ClinConnect Logo
Search / Trial NCT02764463

15 Years Control of Fiber Reenforced Composite Fixed Partial Dentures

Launched by BNM CLINIC AND RESEARCH · May 4, 2016

Trial Information

Current as of May 27, 2025

Unknown status

Keywords

Fiber Reinforced Composites Resin Cements Survival

ClinConnect Summary

As of January 1999, FRC FDPs are offered as alternative to other conventional therapy options at the Department where the study was conducted. Between June-1999 and June-2000, 58 patients aged between 33 and 62 years old (25 females, 33 males, mean age: 47) received 65 indirect posterior FRC FDPs. Before enrolment in the trial, all patients were provided with a written informed consent Information was given to each patient regarding the alternative treatment options. The inclusion criteria were as follows: all subjects were required to be at least 18 years old, able to read and sign the inf...

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • All subjects were required to be at least 18 years old, able to read and sign the informed consent document
  • Physically and psychologically able to tolerate conventional restorative procedures
  • Having no active periodontal or pulpal diseases
  • Having no primary caries
  • Not allergic to resin-based materials
  • Not pregnant or nursing
  • Having antagonist teeth opposing the FRC FDP to be restored
  • Willing to return for follow-up examinations as outlined by the investigators.
  • Exclusion Criteria:
  • Patients who had more absent teeth than the tooth to be replaced in the rest of the dentition or those having diastemas were not excluded.

About Bnm Clinic And Research

bnm Clinic and Research is a leading clinical trial sponsor dedicated to advancing medical science through innovative research and development. With a focus on delivering high-quality, patient-centered clinical trials, bnm Clinic and Research collaborates with healthcare professionals and institutions to evaluate new therapies and treatment modalities across various therapeutic areas. Committed to ethical standards and regulatory compliance, the organization prioritizes participant safety and efficacy while striving to contribute to the improvement of healthcare outcomes globally.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials